Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents

Clin Immunol. 2022 Jan:234:108912. doi: 10.1016/j.clim.2021.108912. Epub 2021 Dec 28.

Abstract

Despite high levels of MMR-II usage in the US, mumps outbreaks continue to occur. Evidence suggests that mumps vaccine-induced humoral immunity wanes over time. Relatively few studies have examined cell-mediated immunity or reported on sex-based differences. To better understand sex-based differences in the immune response to mumps vaccine, we measured neutralizing antibody titers and mumps-specific cytokine/chemokine responses in a cohort of 748 adolescents and young adults after two doses of MMR vaccine. We observed significantly higher neutralizing antibody titers in females than in males (120.8 IU/mL, 98.7 IU/mL, p = 0.038) but significantly higher secretion levels of MIP-1α, MIP-1β, TNFα, IL-6, IFNγ, and IL-1β in males compared to females. These data demonstrate that sex influences mumps-specific humoral and cell-mediated immune response outcomes, a phenomenon that should be considered during efforts to improve vaccines and prevent future outbreaks.

Keywords: Cellular immunity; Chemokine; Cytokine; MMR vaccine; Mumps; Sex-based differences.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Antibodies, Viral / blood*
  • Chemokines / blood
  • Child
  • Cohort Studies
  • Cytokines / blood
  • Female
  • Humans
  • Male
  • Measles-Mumps-Rubella Vaccine / immunology*
  • Mumps virus / immunology*
  • Sex Characteristics
  • Vaccination*
  • Young Adult

Substances

  • Antibodies, Viral
  • Chemokines
  • Cytokines
  • Measles-Mumps-Rubella Vaccine